1. (1) Requirements for services according to phases of treatment:

   1. (a) The patient’s most current phase of treatment, according to the patient’s specific documented history (e.g. patient coming to Facility following transfer from other provider and who may be already under a different phase of treatment), along with rationale for the assigned phase, shall be clearly documented in the patient’s medical record.

   2. (b) For the purposes of this section, the following definitions apply:

      1. 1. “Induction or stabilization” means the phase of treatment when the patient is new to treatment or exhibits active symptoms of substance use disorder and receives more frequent treatment services. The Facility staff should more closely evaluate the patient for signs of reduced symptoms of their substance use disorder, including but not limited to: reduced or eliminated illicit drug use, reduced cravings for illicit substances, suppression of withdrawal symptoms, evaluation of medication side effects, or patient reports of treatment needs.
      2. 2. “Maintenance” means the phase of treatment when the patient demonstrates treatment stability and their substance use disorder is considered to be in remission. Treatment stability is determined by evaluating, but not limited to, the following: stable dosing of the treatment medication, favorable drug screens, reduced or eliminated cravings for illicit substances, regular clinic attendance, participation in counseling, and absence of illegal activity related to illicit substance use.

   3. (c) A patient in the induction or stabilization phases of treatment shall:

      1. 1. Have weekly program provider-interactive visits scheduled with the ability for 1- on-1 therapeutic discussions between the patient and program provider;
      2. 2. Be scheduled to receive appropriate counseling sessions with a qualified counseling provider at least twice a month;
      3. 3. Be administered one (1) observed drug screen initially, and then a drug screen at least weekly, for a minimum of three (3) weeks; and
      4. 4. Be scheduled to receive case management services weekly.

   4. (d) A patient in the maintenance phase of treatment for less than one (1) year shall: OFFICE-BASED OPIATE TREATMENT FACILITIES

      1. 1. Have a scheduled program provider-interactive visit at least every two (2) to four

2. (4) weeks with the ability for 1-on-1 therapeutic discussions between the patient and program provider;

   1. 2. Be scheduled to receive counseling sessions with a qualified counseling provider at least monthly;
   2. 3. Be administered a random drug screen at least eight (8) times annually; and
   3. 4. Be scheduled to receive case management services at least monthly.

   4. (e) A patient in the maintenance phase of treatment for one (1) year or more shall:

      1. 1. Have a scheduled program provider-interactive visit at least every two (2) months with the ability for 1-on-1 therapeutic discussions between the patient and program provider;
      2. 2. Scheduled to receive counseling sessions with a qualified counseling provider at least monthly;
      3. 3. Be administered a random drug screen at least eight (8) times annually; and
      4. 4. Be offered case management services at least every six (6) months. In addition to case management services provided, any offers for case management shall also be documented in the patient’s medical record.
3. (2) All drug screens, regardless of patient phase of treatment, shall be done in accordance with the procedures as detailed in 0940-05-35-.14.

Authority: T.C.A. §§ 4-3-1601, 4-4-103, 33-1-302, 33-1-305, 33-1-309, 33-2-301, 33-2-302, 33-2-402, 33-2-403, 33-2-404, and 33-2-407. Administrative History: New rule filed March 29, 2019; effective June 27, 2019. Amendments filed June 27, 2025; effective September 25, 2025.